HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrick F Sullivan Selected Research

Mitochondrial Diseases (Mitochondrial Disease)

1/2018A Comprehensive Analysis of Nuclear-Encoded Mitochondrial Genes in Schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrick F Sullivan Research Topics

Disease

43Schizophrenia (Dementia Praecox)
01/2023 - 11/2006
8Mental Disorders (Mental Disorder)
01/2024 - 08/2006
4Psychotic Disorders (Schizoaffective Disorder)
01/2023 - 10/2008
4Postpartum Depression (Post-Natal Depression)
01/2022 - 12/2014
4Neurodevelopmental Disorders
01/2022 - 09/2013
4Drug-Related Side Effects and Adverse Reactions
12/2021 - 02/2010
4Bipolar Disorder (Manic Depressive Psychosis)
01/2021 - 12/2014
3Major Depressive Disorder (Major Depressive Disorders)
01/2023 - 12/2014
3Tardive Dyskinesia
01/2020 - 02/2010
3Anorexia Nervosa
01/2019 - 07/2010
3Autistic Disorder (Autism)
01/2018 - 02/2014
3Alcoholism (Alcohol Abuse)
04/2009 - 11/2006
3Personality Disorders (Personality Disorder)
06/2006 - 06/2002
2Genetic Risk Score
01/2023 - 01/2021
2Treatment-Resistant Schizophrenia
12/2021 - 04/2016
2Agranulocytosis (Granulocytopenia)
12/2021 - 09/2014
2Intellectual Disability (Idiocy)
01/2020 - 01/2018
2Parkinson Disease (Parkinson's Disease)
01/2020 - 12/2013
2Obesity
01/2019 - 03/2016
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2018 - 04/2014
2Substance Withdrawal Syndrome (Withdrawal Symptoms)
04/2009 - 11/2006
2Borderline Personality Disorder (Personality Disorders, Borderline)
06/2006 - 01/2003
1Treatment-Resistant Depressive Disorder
01/2023
1COVID-19
12/2022
1Wounds and Injuries (Trauma)
12/2022
1Premature Birth (Birth, Premature)
01/2022
1Inflammation (Inflammations)
01/2022
1Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2022
1Neutropenia
12/2021
1Starvation
12/2020
1Down Syndrome (Down's Syndrome)
01/2020
1Tremor (Tremors)
01/2020
1Dementia (Dementias)
01/2018
1Huntington Disease (Huntington's Disease)
01/2018
1Myoclonus (Nocturnal Myoclonus)
01/2018
1Brain Diseases (Brain Disorder)
01/2018
122q11 Deletion Syndrome
01/2018
1Spasm (Spasms)
01/2018
1Mitochondrial Diseases (Mitochondrial Disease)
01/2018
1Chromosome Inversion (Chromosomal Inversion)
02/2017
1Amebiasis (Amoebiasis)
04/2016
1Prion Diseases (Transmissible Spongiform Encephalopathies)
01/2016

Drug/Important Bio-Agent (IBA)

24Antipsychotic Agents (Antipsychotics)IBA
01/2023 - 02/2007
8Proteins (Proteins, Gene)FDA Link
01/2023 - 02/2014
5Tuberculin (PPD)IBA
12/2022 - 12/2014
5RNA (Ribonucleic Acid)IBA
01/2022 - 09/2013
4Haloperidol (Haldol)FDA LinkGeneric
01/2022 - 06/2012
4LipidsIBA
01/2019 - 03/2016
3Olanzapine (Zyprexa)FDA Link
01/2022 - 10/2008
3DNA (Deoxyribonucleic Acid)IBA
12/2014 - 06/2006
3Estrogens (Estrogen)FDA Link
01/2014 - 11/2006
3Ethanol (Ethyl Alcohol)IBA
04/2009 - 11/2006
3GTP-Binding Proteins (G-Protein)IBA
04/2008 - 03/2006
2Antidepressive Agents (Antidepressants)IBA
01/2023 - 06/2002
2HLA-DQB1 antigen (HLA DQB1)IBA
12/2021 - 09/2014
2Clozapine (Clozaril)FDA LinkGeneric
12/2021 - 09/2014
2ChromatinIBA
01/2018 - 01/2018
2Genetic Markers (Genetic Marker)IBA
01/2018 - 03/2016
2Glucose (Dextrose)FDA LinkGeneric
01/2017 - 03/2013
2Biomarkers (Surrogate Marker)IBA
03/2014 - 06/2009
2Messenger RNA (mRNA)IBA
09/2013 - 02/2010
2EnzymesIBA
05/2008 - 01/2008
2Fluoxetine (Prozac)FDA LinkGeneric
01/2003 - 06/2002
2Nortriptyline (Aventyl)FDA LinkGeneric
01/2003 - 06/2002
1LithiumIBA
01/2023
1GTP Phosphohydrolases (GTPases)IBA
01/2022
1Carrier Proteins (Binding Protein)IBA
01/2022
1Sp4 Transcription FactorIBA
01/2022
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2022
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
01/2022
1Glutamate Receptors (Glutamate Receptor)IBA
01/2022
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2021
1Qa-SNARE Proteins (Syntaxin)IBA
01/2021
1FurinIBA
01/2021
13,4-methylenedioxyethamphetamine (MDEA)IBA
01/2021
1SoilIBA
12/2020
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2020
1Complement C4 (Complement Component 4)IBA
01/2020
1Cholinergic Agents (Cholinergics)IBA
01/2020
1Phosphotransferases (Kinase)IBA
01/2020
1Tyrosine (L-Tyrosine)FDA Link
01/2020
1CalciumIBA
01/2019
1Transcription Factors (Transcription Factor)IBA
01/2018
1Transcription Factor 4IBA
01/2018
1Mitochondrial DNA (mtDNA)IBA
01/2018
1Levetiracetam (Keppra)FDA LinkGeneric
01/2018
1AldosteroneIBA
01/2018
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2018
1Potassium Channels (Potassium Channel)IBA
02/2017
1NetrinsIBA
02/2017
1Insulin (Novolin)FDA Link
01/2017
1HDL CholesterolIBA
01/2017
1Histones (Histone)IBA
04/2016
1Ion Channels (Ion Channel)IBA
03/2016
1ProteomeIBA
03/2016

Therapy/Procedure

2Precision Medicine
01/2024 - 10/2018
2Therapeutics
02/2013 - 10/2011
1Transcutaneous Electric Nerve Stimulation (TENS)
10/2020
1Treatment Delay
01/2018
1Genomic Medicine
04/2016